![](/img/cover-not-exists.png)
AB0060 Adalimumab is more effective than etanercept or abatacept at inhibiting tnf-enhanced human osteoclast development under in vitro conditions of chronic tnf exposure
Harvey, B. P., Kaymakcalan, Z.Volume:
72
Language:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2013-eular.2383
Date:
June, 2013
File:
PDF, 264 KB
english, 2013